Evidence map›Paper›PMID 39220691›Full record

ArticleACS central science2024

One-Step Synthesis of [

Manshu Li, Carla Staton, Xinrui Ma, Weiling Zhao, Liqin Pan, Ben Giglio, Haiden S Berton, Zhanhong Wu, David A Nicewicz, Zibo Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS central science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Manshu LiDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Carla StatonDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Xinrui MaDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Weiling ZhaoDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Liqin PanDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Ben GiglioDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Haiden S BertonDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Zhanhong WuDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
David A NicewiczDepartment of Chemistry University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.ORCID https://orcid.org/0000-0003-1199-9879
Zibo LiDepartment of Radiology, Biomedical Research Imaging Center and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.ORCID https://orcid.org/0000-0002-1063-0298

Funding

Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds SupplementR01EB029451 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO, NICEWICZ, DAVID A · 2020 to 2023
$2.2M
The development of novel PET/NIRF agents for hyperparathyroidism managementR01DK128447 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM, LAWRENCE THOMAS, WU, ZHANHONG · 2021 to 2024
$2.0M
Small Animal PET/CT for Preclinical Imaging ResearchS10OD023611 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO · 2017 to 2017
$835k
NIBIB NIH HHS R01 EB029451NIDDK NIH HHS R01 DK128447NIH HHS S10 OD023611
6 · The paper itself

Abstract

To avoid the harsh conditions that are oftentimes adopted in direct radiofluorination reactions, conjugation of bioactive ligands with

Identifiers

PMID39220691
PMCPMC11363353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.